What question did this study set out to answer?

The aim is to develop 3D tumor models that accurately represent patient tumors and predict responses to various therapies.

Abstract LB334: Patient-derived 3D tumor models integrated with AI-driven treatment matching for target discovery and personalized therapy

View Full Paper

Ask AI

Bookmark

The aim is to develop 3D tumor models that accurately represent patient tumors and predict responses to various therapies.
Developed patient-derived 3D tumoroids and 3D-bioprinted constructs.
Incorporated patient immune cells and vascular channels to enhance model realism.
Evaluated predictive performance in an IRB-approved clinical study with 80 cancer patients.
Integrated AI-driven treatment matching using deep-learning techniques with predictive biomarkers.
Preliminary evidence shows correlation between 3D model responses and clinical outcomes.
In specific cases, AI-selected treatments led to significant and durable clinical responses in patients.
Demonstrated strengths of 3D models in mimicking tumor behavior compared to traditional methods.

No takes yet. Share an insight, caveat, or question.

This clinical trial shows enhanced treatment matching in cancer patients using AI-driven 3D tumor models, suggesting improved outcomes.

Katyal et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark